Guidant's DISCOVERY II pacemaker gets US approval:
This article was originally published in Clinica
Guidant has received US FDA approval for its DISCOVERY II single sensor pacemaker. The device will complement another of the company's sensor products, the PULSAR MAX pacemaker. The DISCOVERY II is designed to simplify clinician interaction with a pacemaker, enabling physicians to easily and efficiently perform comprehensive tests and follow-up operations. The device also provides a concise report that presents information needed for patient management.
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.